Metraipolis › archive › dc_ff099c46770b

Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas — Europe PMC PMID:40992926

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40992926
DOI
10.26508/lsa.202503359
License (as archived)
solo-consultazione
Archived
2026-11-09T19:05:35.604Z
SHA-256 of the archived text
7964ae66a197a0e0f8488863dd6862692624dcba2cdbb578bd77f86b7600edca
Stable URL of this page
https://metraipolis.com/documento/dc_ff099c46770b

How to cite

Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas — Europe PMC PMID:40992926 — Europe PMC (en), https://europepmc.org/article/MED/40992926 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff099c46770b (Metraipolis archive dc_ff099c46770b, sha256 7964ae66a197a0e0f8488863dd6862692624dcba2cdbb578bd77f86b7600edca)
BibTeX
@misc{dcff099c46770b,
  title = {Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas — Europe PMC PMID:40992926},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40992926},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff099c46770b; sha256 7964ae66a197a0e0f8488863dd6862692624dcba2cdbb578bd77f86b7600edca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40992926. Agents can read the archived copy with the MCP tool read_document.